Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia
- 15 October 2009
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 24 (1) , 239-242
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic deathPediatric Blood & Cancer, 2009
- High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseBlood, 2009
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupLeukemia, 2009
- PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viabilityJournal of Clinical Investigation, 2008
- Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemiaNature Medicine, 2007
- Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersNature, 2007
- The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal regionProceedings of the National Academy of Sciences, 1999